A California-based company is seeking US Food and Drug Administration (FDA) authorisation to market what it calls the first “vapour-style inhalable” nicotine replacement therapy (NRT) device ...
Are you already a subscriber? login here
Need help?
Contact a sales representative right now and don’t wait
Erik Galavis
+34 654 320 547
Email Erik
